Stock Events

Stock Events

BioXcel Therapeutics (BX2.F) Q3 2024 Earnings

BX2.F
Aug 6Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.81
-0.6
-0.4
-0.19

Details

Expected EPS
-0.65218132664
Actual EPS
-0.19220459999999998
Surprise EPS
0.46
Surprise Percent
+70.53%

Description

⁨BioXcel Therapeutics⁩ (⁦BX2.F⁩) has reported earnings of ⁦-0.19220459999999998⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts